Donaldson CO INC

Market Movers (8-K)

NYSE
Donaldson Company, Inc. announced the resignation of director Douglas A. Milroy, effective July 31, 2026.
NYSE
Donaldson Company, Inc. has entered into a new three-year, $400 million unsecured delayed draw term loan credit facility to enhance its financial flexibility.
Capital raise
NYSE
Donaldson Company, Inc. announced record second quarter fiscal 2026 sales of $896 million and the strategic acquisition of Facet for $820 million, despite a slight dip in GAAP EPS and lowered full-year guidance.
Worse than expected
Capital raise
NYSE
Donaldson Company, Inc. announced the acquisition of Facet Filtration for $820 million, expanding its presence in mission-critical fuel and fluid filtration markets.
Capital raise
NYSE
Donaldson Company, Inc. announced the appointment of Richard Lewis as its new President and CEO, succeeding Tod Carpenter as part of a planned leadership transition.
NYSE
Donaldson Company achieved record first quarter fiscal 2026 sales and earnings, driven by strong growth in key segments and leading to an upward revision of its full-year adjusted EPS and operating margin guidance.
Better than expected
Capital raise

Quarterly Earnings (10-Q)

NYSE
Donaldson Company announced robust financial results for the third quarter of fiscal year 2026, with net earnings increasing significantly, and also completed a major acquisition.
Capital raise
Better than expected
NYSE
Donaldson Company reports mixed second-quarter results with increased net sales and diluted EPS for the six-month period, but a slight dip in quarterly net earnings, while announcing a significant acquisition.
Delay expected
Worse than expected
Capital raise
NYSE
Donaldson Company, Inc. reported a robust first quarter for fiscal 2026, with net earnings increasing 15.1% and diluted EPS up 19.0% year-over-year, driven by strong performance in Mobile Solutions and Life Sciences segments.
Better than expected
NYSE
Donaldson Company, Inc. reported a significant 49.1% drop in net earnings for the third fiscal quarter of 2025, primarily driven by a $62.0 million impairment charge on intangible assets in its Life Sciences segment, despite a modest increase in net sales.
Worse than expected
Capital raise
Delay expected
NYSE
Donaldson Company's Q2 2025 net sales decreased slightly, with growth in Life Sciences offset by declines in Mobile and Industrial Solutions.
Worse than expected
NYSE
Donaldson Company's first quarter fiscal 2025 results show a 6.4% increase in net sales compared to the same period last year, driven by volume growth and positive currency translation.
Better than expected

Annual Reports (10-K)

NYSE
Donaldson Company, Inc. reported a decrease in net earnings and diluted EPS for fiscal year 2025, primarily due to a significant impairment charge in its Life Sciences segment.
Delay expected
Worse than expected
NYSE
Donaldson Company, Inc.'s 10-K filing reveals a year of solid growth, driven by strategic initiatives and strong performance across its Mobile, Industrial, and Life Sciences segments.
Better than expected

Insider Trading (Form 4)

NYSE
DONALDSON Co Inc reports a transaction where Director Jacinth C. Smiley acquired 267 shares of common stock.
NYSE
Trudy A. Rautio, a Director at DONALDSON Co INC, acquired 334 shares of common stock on July 3, 2026.
NYSE
Director James Owens of Donaldson Co. Inc. reported the acquisition of 267 shares of common stock on July 3, 2026, at a price of $89.09 per share.
NYSE
Christopher M. Hilger, a Director at Donaldson Co. Inc., acquired 400 shares of common stock on July 3, 2026, at a price of $89.09 per share.
NYSE
James Owens, a Director at Donaldson Co. Inc. (DCI), reported a series of transactions involving the acquisition and disposition of common stock and stock options.
NYSE
Director Jacinth C. Smiley acquired 279 shares of Donaldson Co Inc (DCI) common stock at a price of $85.23 per share.

Proxy Statements (Def-14A)

NYSE
Analysis of the specified SEC DEFA14A filing is unavailable as the document content was not provided for review.
NYSE
Donaldson Company, Inc. announces its 2025 Annual Meeting of Stockholders, detailing director elections, executive compensation, and auditor ratification, alongside reporting record adjusted operating margin and EPS for fiscal 2025.
Better than expected
NYSE
Donaldson Company, Inc. has filed definitive additional materials related to its proxy statement with the Securities and Exchange Commission.
NYSE
Donaldson Company, Inc. will hold its annual meeting of stockholders virtually on November 22, 2024, to elect directors, vote on executive compensation, and ratify the appointment of its independent accounting firm.
Better than expected

Schedule 13G - Passive Investments

NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 5.23% beneficial ownership stake in Donaldson Company, Inc.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.64% of Donaldson Co Inc's common stock as of March 31, 2026.
NYSE
The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Donaldson Co Inc following an internal realignment.